trending Market Intelligence /marketintelligence/en/news-insights/trending/x3juxim8codjw5w-smyxqg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

CytoDyn raises $1.1M via private placements of shares, warrants

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

CytoDyn raises $1.1M via private placements of shares, warrants

CytoDyn Inc., a U.S. developer of antibodies to treat HIV, raised about $1.1 million in gross proceeds through private placements of shares and warrants sold together at 50 cents per fixed combination.

Each fixed combination comprised 1 common share and 0.5 of a warrant.

A whole warrant entitles the holder to buy a common share for 75 cents and can be exercised for five years.

In total, Vancouver, Wash.-based CytoDyn sold 2,110,000 common shares along with warrants to buy 1,055,000 common shares.

CytoDyn has given the placement agent an option to purchase warrants for 181,000 common shares at terms similar to the offering.

This is the company's third such offering since September. CytoDyn raised $6.5 million and $1.4 million in the first two placements.